Drug licences of 9 pharma dealers suspended in Jammu

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, the official said

Jammu:  Authorities here on Saturday suspended drug sale licences of nine dealers in a special drive carried out to curb misuse of pharmaceuticals with habit forming ingredients, an official said.

The drive was conducted by the J-K Drugs and Food Control Organisation to identify and take punitive action against “unscrupulous elements dealing with such drugs in a clandestine manner,” an official spokesperson said.

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, he said.

The ingredient was being sourced directly from the suppliers based outside Jammu and Kashmir illegally, he said.

More scrutiny revealed that the firms procured and distributed these medicinal preparations without maintaining the sales records as mandated under the Drugs & Cosmetics Act, 1940, the spokesperson said. S

Stocks of pharmaceutical preparations, which are prone to addiction, worth over Rs 13.58 lakh were also seized, he said.

J-K State Drugs Controller Lotika Khajuria warned against indulging in procuring lesser-known brands of drugs formulations consisting of habit forming ingredients directly from the suppliers, or manufacturers located outside J-K.

“In case any violation is reported, the defaulters shall be dealt strictly in accordance with zero-tolerance policy adopted by the government against persons involved in promoting drug abuse which warrants the cancellation of such licences as also legal mandate,” she said.

Related Posts

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy